ASPE:NASDAQ, Aspen Neuroscience Inc.

ASPE stock overview

Aspen Neuroscience Inc. (ASPE:NASDAQ) closed at $12.42 on November 20, 2026, up 0.24% on the day. The stock trades 16.6% below its 52-week high of $14.90 and 10.9% above its 52-week low of $11.20. Over the past year, it lost 16.6%. Aspen Neuroscience Inc. is part of the Health Care sector.

Key figures

Price
$12.42
Day change
+0.24%
Volume
130,038
Average volume
367,246
Market cap
361M+
52-week range
$11.20 – $14.90
50-day average
$12.74
200-day average
$12.74

Recent signals

ASPE news

About Aspen Neuroscience Inc.

Aspen Neuroscience, Inc. is a clinical-stage regenerative medicine biotechnology company focused on developing autologous induced-pluripotent stem cell (iPSC)-derived therapies to address neurodegenerative diseases with high unmet medical need.

Similar stocks

Find more stocks like ASPE with the Spikes, Gaps, Breakouts and Performance Tracker scanners.

Based on end-of-day data. For information only, not investment advice.